Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04056637 · ClinicalTrials.gov registry record · NA
Choice of Modality of Follow up for Medication Abortion
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04056637: Clinical Trial NA study, sponsored by Stanford University.
NCT04056637 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04056637, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study will assess the impact of providing medication abortion-seeking clients a choice for follow-up in practice. Clients presenting at or less than 63 days pregnant (based on last menstrual period) at the study site for first trimester medication abortion will be invited to participate. We hypothesize that providing clients with flexible follow-up options will improve follow-up rates. This study is not to assess efficacy or safety of follow-up methods--that has been well established in practice and research. This is to assess choice of follow-up.
Interventions
- DEVICE Multi-level pregnancy test
- OTHER Choice of follow-up option
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04056637
The ClinicalTrials.gov registry entry for NCT04056637 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Multi-level pregnancy test is the first listed.
NCT04056637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04056637 about?
NCT04056637 is a clinical study titled "Choice of Modality of Follow up for Medication Abortion". This study will assess the impact of providing medication abortion-seeking clients a choice for follow-up in practice. Clients presenting at or less than 63 days pregnant (based on last menstrual period) at the study site for first trimester medication abortion will be invited to participate. We hyp...
What is the current status of trial NCT04056637?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2019-09-09. Estimated completion is 2020-03-31.
What interventions are being tested in trial NCT04056637?
The interventions under investigation include: Multi-level pregnancy test (DEVICE), Choice of follow-up option (OTHER).
Who is sponsoring clinical trial NCT04056637?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.